The Effect On Self-Care and Self-Efficacy of Inhaler Training in COPD

COPD Clinical Trial

Official title:

The Effect On Self-Care and Self-Efficacy of Inhaler Training in COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04052906
• Other study ID #: NevsehirHBVU
• Status: Completed
• Phase: N/A
• Start date: November 1, 2017
• Est. completion date: May 1, 2018

Study information

• Verified date: November 2019
• Source: Nevsehir Haci Bektas Veli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to evaluate the effect of planned inhaler medication training on self-care agency and self-efficacy level.

Description:

Pulmonary diseases are a major source of mortality and morbidity globally. The major symptom of COPD is dyspnea. Since dyspnea leads to activity limitation and inadequate self-care skills among individuals, it is often associated with major psychological comorbidity, social isolation and poor perceived quality of life. COPD patients with high self-efficacy are high enough to level of treatment adherence. On the other hand, the most preferred treatment method for the management and mitigation of COPD symptoms is by the use of inhaler medication. However, incorrect use of the inhaler would lead to failure in the control of COPD patients. Also, it fails to provide COPD patients with self-care agency and self-efficacy levels. In COPD, planned inhaler medication training has been shown in many studies to reduce dyspnoea, increase self-care and self-efficacy levels. Therefore, planned inhaler medication training increases quality of life in COPD patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 67
• Est. completion date: May 1, 2018
• Est. primary completion date: February 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Subjects who are literate,

• Diagnosed with COPD at least six months ago,

• Using inhaler medication since three or more months,

• Moderate or severe COPD, according to GOLD criteria,

• Incorrect use inhaler medication uses according to the list of inhaler medication use skills,

• No communication problems,

• No mental confusion or any psychiatric problem,

• Agrees to participate in the study.

Exclusion Criteria:

• Cognitive dysfunction,

• Severe pulmonary, cardiological or malignant disease,

• In a period of exacerbation,

• Correctly performs all steps for their prescribed inhaler medication(s), according to the list of inhaler skills.

Related Conditions & MeSH terms

• COPD

Intervention

Other:
• Training
Planned Inhaler Medication Trainning

Locations

Country	Name	City	State
Turkey	Gamze Muz	Nevsehir

Sponsors (1)

Lead Sponsor	Collaborator
Nevsehir Haci Bektas Veli University

Country where clinical trial is conducted

Turkey, 

References & Publications (6)

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6. — View Citation

Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-81. — View Citation

FLETCHER CM. The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med. 1952 Sep;45(9):577-84. — View Citation

Göris S, Tasci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):336-44. doi: 10.1089/jamp.2012.1017. Epub 2013 Feb 19. — View Citation

Kearney BY, Fleischer BJ. Development of an instrument to measure exercise of self-care agency. Res Nurs Health. 1979 Mar;2(1):25-34. — View Citation

Wigal JK, Creer TL, Kotses H. The COPD Self-Efficacy Scale. Chest. 1991 May;99(5):1193-6. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	COPD Self-Efficacy Scale (CSES)	CSES developed by Wigal et al. (1991) is used to determine the degree of confidence that COPD patients have in managing or avoiding breathing difficulty during certain activities. The scale consists of 34 items and 5 subscales.	baseline to the 3 months after intervention
Primary	Self-Care Agency Scale	The Self-care Agency Scale (1979) was developed by Kearney and Fleischer, and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. With this scale consisting of 35 items, patients evaluate their ability or agency to perform self-care actions.	baseline to the 3 months after intervention
Secondary	Modified Borg Dyspnea Scale	While the Modified Borg Scale is nowadays generally used to define the severity of dyspnea in exercise, it can also be used to assess the severity of resting dyspnea	baseline to the 3 months after intervention
Secondary	Medical Research Council (MRC) Dyspnea Scale	The dyspnea scale is a 1 to 5 score scale consisting of five items based on various physical activities that produce a feeling of dyspnea.	baseline to the 3 months after intervention